Pds Biotechnology Corp (PDSB)

Finanzdaten der Pds Biotechnology Corp-Aktie (PDSB)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	0.37%6.50	6.52	6.67	8.14	7.62
Research and Development	5.54%3.27	3.46	4.41	4.58	4.21
Operating Income/Loss	0.37%-6.50	-6.52	-6.67	-8.14	-7.62
Income/Loss From Continuing Operations Before Tax	32.68%-9.75	-7.35	-7.56	-9.01	-9.43
Income Tax Expense/Benefit, Current	-	-	-1.17	-	-
Income Tax Expense/Benefit	-	-	-	-	-
	32.68%-9.75	-7.35	-7.56	-9.01	-9.43
Attributable To Parent	32.68%-9.75	-7.35	-7.56	-9.01	-9.43
Basic Average Shares	0.29%55.66	55.50	-	46.87	45.90
Diluted Average Shares	0.29%55.66	55.50	-	46.87	45.90
Basic Earnings Per Share	38.46%-0.18	-0.13	-	-0.19	-0.21
Diluted Earnings Per Share	38.46%-0.18	-0.13	-	-0.19	-0.21